カテゴリ： IMARC, 世界, 医療/バイオ

セファロスポリンのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）

■ 英語タイトル：Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

調査会社IMARC社が発行したリサーチレポート（データ管理コード：IMARC23FB0199）■ 発行会社/調査会社：IMARC
■ 商品コード：IMARC23FB0199
■ 発行日：2023年2月1日
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：110
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥449,850見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥599,850見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥749,850見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※IMARC社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[セファロスポリンのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

IMARC社の市場調査書では、2022年に187億ドルであった世界のセファロスポリン市場規模が2028年に223億ドルへ増加し、2023年から2028年の間にCAGR 2.83％拡大すると推測されています。当書では、セファロスポリンの世界市場を調査対象とし、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、世代別（第一世代、第二世代、第三世代、第四世代、第五世代）分析、投与経路別（注射剤、経口剤）分析、用途別（呼吸器科、皮膚感染症、耳感染症、尿路感染症、その他）分析、地域別（アジア太平洋、ヨーロッパ、北米、中東・アフリカ、中南米）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競合状況などを整理しました。並びに、当書に掲載されている企業情報には、Allergan Plc.、Bristol-Myers Squibb Company、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline plc、Lupin Limited、Merck & Co. Inc.、Novartis International AG (Sandoz)、Pfizer Inc.、Sanofi、Teva Pharmaceutical Industries Ltd.、Abbott、Sun Pharmaceutical Industries Limitedなどが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界のセファロスポリン市場規模：世代別
- 第一世代セファロスポリンの市場規模
- 第二世代セファロスポリンの市場規模
- 第三世代セファロスポリンの市場規模
- 第四世代セファロスポリンの市場規模
- 第五世代セファロスポリンの市場規模
・世界のセファロスポリン市場規模：投与経路別
- 注射剤における市場規模
- 経口剤における市場規模
・世界のセファロスポリン市場規模：用途別
- 呼吸器科における市場規模
- 皮膚感染症における市場規模
- 耳感染症における市場規模
- 尿路感染症における市場規模
- その他用途における市場規模
・世界のセファロスポリン市場規模：地域別
- アジア太平洋のセファロスポリン市場規模
- ヨーロッパのセファロスポリン市場規模
- 北米のセファロスポリン市場規模
- 中東・アフリカのセファロスポリン市場規模
- 中南米のセファロスポリン市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競合状況

The global cephalosporin market size reached US$ 18.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.3 Billion by 2028, exhibiting a growth rate (CAGR) of 2.83% during 2023-2028.

Cephalosporins are beta-lactam antibiotics that function in the way similar to penicillin. These broad-spectrum drugs help in treating numerous bacterial infections such as pneumonia, kidney infections, bone infections, meningitis and various sexually transmitted diseases (STDs). There are currently five generations of cephalosporin drugs available in the market with a slight difference in their antibacterial spectrum. These medicines are also differentiated on the basis their administration, excretion, absorption and the duration of the effect of cephalosporin on the body. There are two ways to administer cephalosporin drugs, namely, oral and intravenous (IV). A course of oral cephalosporins is generally used for curing minor infections that are easy to treat such as strep throat. Whereas, IVs are utilized for more severe infections, like meningitis, as these medicines reach tissues quickly than those administered orally.

At present, the rapidly increasing water and air pollution are the primary reasons for the prevalence of infectious diseases across the globe. This has provided a boost to the demand for cephalosporin drugs worldwide. Other than this, various organizations around the world are taking initiatives to improve the development and delivery of antibiotic treatments. One such program is the Global Antibiotic Research and Development Partnership (GARDP), which is a not-for-profit R&D organization formed by the Drugs for Neglected Disease initiative (DNDi) and World Health Organization (WHO). It focusses on the promotion of public-private partnerships for increasing R&D of new antimicrobial diagnostics and agents. The formation of these partnerships is expected to play a significant role in the growth of the cephalosporin market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cephalosporin market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on generation, route of administration and application.

Breakup by Generation:

First Generation
Second Generation
Third Generation
Fourth Generation
Fifth Generation

Breakup by Route of Administration:

Injection
Oral

Breakup by Application:

Respiratory Tract
Skin Infection
Ear Infection
Urinary Tract Infection
Sexually Transmitted Infection
Others

Breakup by Region:

Asia Pacific
Europe
North America
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Lupin Limited, Merck & Co. Inc., Novartis International AG (Sandoz), Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Abbott, Sun Pharmaceutical Industries Limited, etc.

Key Questions Answered in This Report
1. What was the size of the global cephalosporin market in 2022?
2. What is the expected growth rate of the global cephalosporin market during 2023-2028?
3. What are the key factors driving the global cephalosporin market?
4. What has been the impact of COVID-19 on the global cephalosporin market?
5. What is the breakup of the global cephalosporin market based on the generation?
6. What is the breakup of the global cephalosporin market based on the route of administration?
7. What are the key regions in the global cephalosporin market?
8. Who are the key players/companies in the global cephalosporin market?

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cephalosporin Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Generation
5.5 Market Breakup by Route of Administration
5.6 Market Breakup by Application
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Generation
6.1 First Generation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Second Generation
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Third Generation
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Fourth Generation
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Fifth Generation
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Injection
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Respiratory Tract
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Skin Infection
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ear Infection
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Urinary Tract Infection
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Sexually Transmitted Infection
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Region
9.1 Asia Pacific
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Europe
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 North America
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Allergan Plc.
14.3.2 Bristol-Myers Squibb Company
14.3.3 F. Hoffmann-La Roche Ltd.
14.3.4 GlaxoSmithKline plc
14.3.5 Lupin Limited
14.3.6 Merck & Co. Inc.
14.3.7 Novartis International AG (Sandoz)
14.3.8 Pfizer Inc.
14.3.9 Sanofi
14.3.10 Teva Pharmaceutical Industries Ltd.
14.3.11 Abbott
14.3.12 Sun Pharmaceutical Industries Limited

Figure 1: Global: Cephalosporin Market: Major Drivers and Challenges
Figure 2: Global: Cephalosporin Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cephalosporin Market: Breakup by Generation (in %), 2022
Figure 4: Global: Cephalosporin Market: Breakup by Route of Administration (in %), 2022
Figure 5: Global: Cephalosporin Market: Breakup by Application (in %), 2022
Figure 6: Global: Cephalosporin Market: Breakup by Region (in %), 2022
Figure 7: Global: Cephalosporin Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Cephalosporin (First Generation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Cephalosporin (First Generation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Cephalosporin (Second Generation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cephalosporin (Second Generation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cephalosporin (Third Generation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cephalosporin (Third Generation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cephalosporin (Fourth Generation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cephalosporin (Fourth Generation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cephalosporin (Fifth Generation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cephalosporin (Fifth Generation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cephalosporin (Injection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cephalosporin (Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cephalosporin (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cephalosporin (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cephalosporin (Respiratory Tract) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cephalosporin (Respiratory Tract) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cephalosporin (Skin Infection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cephalosporin (Skin Infection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Cephalosporin (Ear Infection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Cephalosporin (Ear Infection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Cephalosporin (Urinary Tract Infection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Cephalosporin (Urinary Tract Infection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Cephalosporin (Sexually Transmitted Infection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Cephalosporin (Sexually Transmitted Infection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Cephalosporin (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Cephalosporin (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia Pacific: Cephalosporin Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia Pacific: Cephalosporin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Europe: Cephalosporin Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Europe: Cephalosporin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Cephalosporin Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: North America: Cephalosporin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Middle East and Africa: Cephalosporin Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Middle East and Africa: Cephalosporin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Latin America: Cephalosporin Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Latin America: Cephalosporin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Cephalosporin Industry: SWOT Analysis
Figure 45: Global: Cephalosporin Industry: Value Chain Analysis
Figure 46: Global: Cephalosporin Industry: Porter’s Five Forces Analysis

Table 1: Global: Cephalosporin Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cephalosporin Market Forecast: Breakup by Generation (in Million US$), 2023-2028
Table 3: Global: Cephalosporin Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Cephalosporin Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Cephalosporin Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Cephalosporin Market Structure
Table 7: Global: Cephalosporin Market: Key Players

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • セファロスポリンのグローバル市場（～2030年）：第一世代セファロスポリン、第二世代セファロスポリン、第三世代セファロスポリン、第四世代セファロスポリン、第五世代セファロスポリン
  • 多形性膠芽腫治療のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • 鎮痛剤のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • 造影剤のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • バイオインプラントのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IMARC23FB0199 )"セファロスポリンのグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）" (英文：Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)はIMARC社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。